Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marcelo V. Negrao"'
Autor:
Lei Feng, Jacqulyne P. Robichaux, Yasir Elamin, Jianjun Zhang, Brett W. Carter, Don L. Gibbons, George R. Blumenschein, John V. Heymach, Frank E. Mott, Mehmet Altan, Marcelo V. Negrao, Vincent K. Lam, Frank V. Fossella, Anisha B. Patel, Anne S. Tsao, Xiuning Le
Publikováno v:
J Clin Oncol
PURPOSE Targeted therapies against non–small-cell lung cancer (NSCLC) harboring HER2 mutations remain an unmet need. In this study, we assessed the efficacy and safety of poziotinib in patients with HER2 exon 20 mutant advanced NSCLC in a single-ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce847f3cddbf0739c9448e42355323c1
https://europepmc.org/articles/PMC8887948/
https://europepmc.org/articles/PMC8887948/
Autor:
V.A. Miller, Yasir Elamin, Alissa Poteete, John V. Heymach, L. Hu, Monique B. Nilsson, G.M. Frampton, R. S. K. Vijayan, Junqin He, Richard B. Lanman, Kwok K. Wong, Alexa B. Schrock, Jacqulyne P. Robichaux, Xiuning Le, Fahao Zhang, Victoria M. Raymond, Cross Jason, Marlese Pisegna, Huiying Sun, Marcelo V. Negrao
Publikováno v:
Journal of Thoracic Oncology. 15:S9-S10
Autor:
Anne Tsao, Monique B. Nilsson, John V. Heymach, Yasir Elamin, Mehmet Altan, L. Hu, Jonathan M. Kurie, Z. Yang, Vincent K. Lam, Brent Roeck, Frank V. Fossella, George R. Simon, George R. Blumenschein, Frank E. Mott, Brett W. Carter, Marcelo V. Negrao, Junqin He, Jacqulyne P. Robichaux, Vassiliki A. Papadimitrakopoulou, Don L. Gibbons
Publikováno v:
Journal of Thoracic Oncology. 14:S282-S283
Autor:
Garrett M. Frampton, Jordi Rodon Ahnert, Huiying Sun, Ting Chen, Lemei Hu, R. S. K. Vijayan, Zane Yang, John V. Heymach, Monique B. Nilsson, Kwok-Kin Wong, Funda Meric-Bernstam, Marcelo V. Negrao, Alexa B. Schrock, Brent Roeck, Junqin He, Cross Jason, Alissa Poteete, Richard B. Lanman, Xiuning Le, Jacqulyne P. Robichaux, Jing Wang, Fahao Zhang, Victoria M. Raymond, Mark J. Routbort, Shuai Li, Marlese Pisegna, Vincent A. Miller, Yasir Elamin, Lee A. Albacker, Lixia Diao, Han Han
Publikováno v:
Cancer Cell
We characterized the landscape and drug sensitivity of ERBB2 (HER2) mutations in cancers. In 11 datasets (n = 211,726), ERBB2 mutational hotspots varied across 25 tumor types. Common HER2 mutants yielded differential sensitivities to eleven EGFR/HER2
Autor:
Vassiliki A. Papadimitrakopoulou, George R. Simon, Brett W. Carter, Marcelo V. Negrao, Z. Yang, John V. Heymach, Lei Feng, Yasir Elamin, Don L. Gibbons, Frank E. Mott, Jonathan M. Kurie, Frank V. Fossella, Vincent K. Lam, Anne Tsao, Brent Roeck, D. Mack, Mehmet Altan, George R. Blumenschein, Anisha B. Patel, Dennis L. Jenkins, Jacqulyne P. Robichaux
Publikováno v:
Journal of Thoracic Oncology. 13:S323-S324
Autor:
Chang-Jiun Wu, Monique B. Nilsson, Stephen G. Swisher, Waree Rinsurongkawong, Xiuning Le, Bonnie S. Glisson, Andrew Futreal, John V. Heymach, Emily Roarty, Jianjun Zhang, Lara C.A. Landry, Marcelo V. Negrao, Alexandre Reuben, Jianhua Zhang, George R. Simon, Jacqulyne P. Robichaux
Publikováno v:
Journal of Clinical Oncology. 36:9052-9052
9052Background: Immune checkpoint blockade has led to unprecedented durable clinical benefit in metastatic non-small cell lung cancer (NSCLC), but response rates are low for patients with targetabl...